Language Selection

YOU ARE USING THE CNPHI QA SYSTEM (LIBERTY)
Français

Molecular Detection

<<Return to Search Results

Requisition Forms

Reference Details

Description:

Molecular detection of vancomycin resistant genes vanA, vanB, vanC, vanD, vanE, vanL, and vanG in vancomycin-resistant enterococcus (VRE).

Test Category:
Molecular Detection
Pathogen:
Vancomycin-Resistant Enterococcus (VRE)
Illnesses and Diseases:
  • Bacterial endocarditis
Specimen:

Pure culture.

Collection Method:

N/A

Specimen Processing, Storage and Shipping:

Send cultures as growth on culture medium or in transport medium.

Transportation of Dangerous Goods:

Shipping of specimens shall be done by a TDG certified individual in accordance with TDG regulations. For additional information regarding classification of specimens for the purposes of shipping, consult either Part 2 Appendix 3 of the TDG Regulations or section 3.6.2 of the IATA Dangerous Goods Regulations as applicable.

Patient Criteria:

Patient should have symptoms consistent with infection with VRE which can include urinary tract infection (UTI), bacteremia, bacterial endocarditis, or meningitis.

Accompanying Documentation:

Completed Antimicrobial Resistance and Nosocomial Infections Requisition.

Comments:

N/A

Methods and Interpretation of Results:

Results are compared to known controls.

Turnaround Time:

5 calendar days.

Contact:
Phone #: (204) 789-5000
Fax: (204) 789-5020
References:
  1. Boyd, D.A., B.M. Willey, D. Fawcett, N. Gillani, and M.R. Mulvey. Molecular Characterization of Enterococcus faecalis N06-0364 with Low-Level Vancomycin Resistance Harboring a Novel D-Ala-D-Ser Gene Cluster, vanL. Antimicrobial Agents and Chemotherapy. 2008. 52:2667-72.
  2. Boyd, D.A., T. Du, R. Hizon, B. Kaplen, T. Murphy, S. Tyler, S. Brown, F. Jamieson, K. Weiss, M.R. Mulvey, and the Canadian Nosocomial Infection Surveillance Program. 2006. VanG-type vancomycin resistant Enterococcus faecalis isolated in Canada. Antimicrobial Agents and Chemotherapy. 50:2217-2221.
  3. Boyd, D.A., M.A. Miller, and M.R. Mulvey. 2006. E. gallinarum N04-0414 harbors a VanD-type vancomycin resistance operon and does not contain a D-alanine:D-alanine 2 (ddl2) gene. Antimicrobial Agents and Chemotherapy. 50:1067-1070.
  4. Boyd, D., P. Kibsey, D. Roscoe, M.R. Mulvey and the Canadian Nosocomial Infection Surveillance Program (CNISP). 2004. Enterococcus faecium N03-0072 carries a new VanD-type vancomycin resistance; characterization of the vanD5 operon. Journal of Antimicrobial Chemotherapy. 54:680-683.
  5. Boyd, D., T. Cabral, P. Van Caeseele, J. Wylie, and M.R. Mulvey. 2002. Molecular characterization of the vanE gene cluster in vancomycin-resistant Enterococcus faecalis N00-410 isolated in Canada. Antimicrobial Agents and Chemotherapy. 46:1977-1979.
  6. Elsayed, S., N. Hamilton, D. Boyd, and M.R. Mulvey. 2001. Improved primer design for multiplex PCR analysis of vancomycin-resistant Enterococcus spp. Journal of Clinical Microbiology 39:2367-2368.
  7. Boyd, D.A., J. Conly, H. Dedier, G. Peters, L. Robertson, E. Slater, and M.R. Mulvey. 2000. Molecular characterization of the vanD gene cluster and a novel insertion element in a vancomycin-resistant Enterococcus isolated in Canada. Journal of Clinical Microbiology 38:2392-2394.
Guidelines:
Related Information: